Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 10/13/2025 | $90.00 | Neutral → Underperform | BofA Securities |
| 10/2/2025 | $105.00 | Hold → Buy | The Benchmark Company |
| 4/21/2025 | $50.00 | Buy → Neutral | B. Riley Securities |
| 2/12/2025 | Outperform → Mkt Perform | William Blair | |
| 11/8/2024 | Buy → Hold | The Benchmark Company | |
| 5/3/2024 | $130.00 | Hold → Buy | Craig Hallum |
| 12/15/2023 | Buy → Neutral | BofA Securities | |
| 9/15/2023 | $225.00 | Buy | BofA Securities |
Hexcel Corporation (NYSE:HXL) announced today that James (Jamie) Coogan has been appointed Executive Vice President and Chief Financial Officer effective May 1, 2026. He will report to Tom Gentile, Hexcel Chairman, CEO and President. Coogan succeeds Mike Lenz who has been serving as interim Chief Financial Officer. Lenz will remain for a period of time when Coogan joins the company as a Senior Advisor to assist with the transition. "Jamie brings the experience and the financial leadership that will help Hexcel build on our momentum as we enter a period of growth with rising commercial aircraft production rates and an expanding defense and space market," said Tom Gentile, Chairman, CEO and
David Ryzhik Appointed Interim Chief Financial OfficerBEVERLY, Mass., March 12, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced that David Ryzhik, Senior Vice President of Investor Relations and Corporate Strategy, has been appointed Interim Chief Financial Officer, effective March 12. James Coogan is leaving the Company to pursue a CFO opportunity at a public company in a different industry and will remain with the Company through April 24 to ensure a smooth transition. Axcelis will initiate a search process with the assistance of a leading executive search firm to identify its next CFO.
BEVERLY, Mass., Feb. 23, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today the company's plans to participate in the following upcoming investor conferences: The Susquehanna Financial Group Fifteenth Annual Technology Conference, taking place at the Lotte New York Palace Hotel on February 26th and virtually on February 27th, 2026. Axcelis management will host one-on-one and small group meetings on Thursday, February 26th with interested investors. For more infor
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
8-K - AXCELIS TECHNOLOGIES INC (0001113232) (Filer)
10-K - AXCELIS TECHNOLOGIES INC (0001113232) (Filer)
8-K - AXCELIS TECHNOLOGIES INC (0001113232) (Filer)
BofA Securities downgraded Axcelis Tech from Neutral to Underperform and set a new price target of $90.00
The Benchmark Company upgraded Axcelis Tech from Hold to Buy and set a new price target of $105.00
B. Riley Securities downgraded Axcelis Tech from Buy to Neutral and set a new price target of $50.00
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
4 - AXCELIS TECHNOLOGIES INC (0001113232) (Issuer)
Q4 Highlights:Revenue of $238 millionGAAP Gross Margin of 47.0%, and Non-GAAP Gross Margin of 47.3%GAAP Operating Margin of 15.2% and Non-GAAP Operating Margin of 21.1%GAAP Diluted Earnings Per Share of $1.10, and Non-GAAP Diluted Earnings Per Share of $1.49BEVERLY, Mass., Feb. 17, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced financial results for the fourth quarter and full year ended December 31, 2025. President and CEO Russell Low commented, "Axcelis exited 2025 on a strong note with fourth quarter results that exceeded our outlook. We achieve
BEVERLY, Mass., Jan. 26, 2026 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry will release financial results for the fourth quarter and full year 2025 after market close on Tuesday, February 17, 2026. The Company will host a call to discuss the results for the fourth quarter and full year 2025 on Tuesday, February 17, 2026, at 5:00 p.m. ET. The call will be available via webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by register
Q3 Highlights: Revenue of $213.6 millionGAAP Gross Margin of 41.6%, and Non-GAAP Gross Margin of 41.8%GAAP Operating Margin of 11.7% and Non-GAAP Operating Margin of 18.2%GAAP Diluted earnings per share of $0.83, and Non-GAAP Diluted earnings per share of $1.21BEVERLY, Mass., Nov. 4, 2025 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS) today announced financial results for the third quarter ended September 30, 2025. President and CEO Russell Low commented, "We delivered another solid quarter, with sales and earnings both exceeding our expectations. We are also pleased
The Company Announces Planned Retirement of Doug Lawson, Executive Vice President of Corporate Marketing and Strategy BEVERLY, Mass., June 27, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, today named David Ryzhik as Senior Vice President of Investor Relations and Corporate Strategy, assuming responsibility for the role in July 2024. The Company also announced the retirement of Doug Lawson, Executive Vice President of Corporate Marketing and Strategy. Mr. Lawson plans to retire in July 2024 and will remain as a Senior Advisor through July 2025.
BEVERLY, Mass., April 2, 2024 /PRNewswire/ -- Axcelis Technologies, Inc. (NASDAQ:ACLS), a leading supplier of enabling ion implantation solutions for the semiconductor industry, announced today a shipment of the Company's Purion EXE™ SiC high energy implanter as well as a successful Purion H200™ SiC medium energy implanter evaluation closure at leading power device chipmakers located in Japan. The systems will be used for 150mm and 200mm production of silicon carbide power devices supporting automotive, industrial, energy, and other power intensive applications. Greg Redinbo,
SOLANA BEACH, Calif., July 15, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (NASDAQ:CLPT) (the "Company"), a global therapy-enabling platform company providing navigation and delivery to the brain, is pleased to announce that Lynnette C. Fallon has been appointed to the Company's Board of Directors effective immediately. Ms. Fallon will also become a member of the Company's Audit Committee. Ms. Fallon is the Executive Vice President, HR/Legal, General Counsel and Secretary of Axcelis Technologies, Inc. (NASDAQ:ACLS), a provider of equipment and service solutions for the semiconductor manufacturing industry, with locations in eight countries. Ms. Fallon has held her current position sin
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)
SC 13G/A - AXCELIS TECHNOLOGIES INC (0001113232) (Subject)